Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Aavis Pharmaceuticals logo — USFDA-approved manufacturer of specialty generic medications...

Aavis Pharmaceuticals

USFDA-approved manufacturer of specialty generic medications founded in 2015 and based in Hoschton, Georgia.

Founded 2015 United States United States 50 employees Series Unknown Total: $2.48M

General Information

Company Name Aavis Pharmaceuticals
Founded Year 2015
Location United States United States +1
Employees 50
Funding Stage Series Unknown
Social

Get notified when Aavis Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Aavis Pharmaceuticals

Aavis Pharmaceuticals is a USFDA-approved manufacturer of specialty generic medications founded in 2015 and based in Hoschton, Georgia. The company is engaged in Contract Development and Manufacturing of Generic Pharmaceuticals. Aavis Pharmaceuticals has positioned itself as one of the fastest-growing pharmaceutical companies in the Atlanta Region, USA.

They are focused on developing niche generic drugs with expertise in advanced scientific research, process development, patent analysis, regulatory compliance, and market & competition analysis. With a commitment to continuous improvement in manufacturing processes, technology, and possible vertical integration, Aavis is aiming to be a market leader in the generics they develop.

The company's last investment of $600.00K came from a Venture Round investment on 24 October 2017. The investors behind this round are not disclosed.

Taxonomy: USFDA-approved, specialty generic medications, Contract Development and Manufacturing, pharmaceutical company, generic drugs, scientific research, process development, patent analysis, regulatory compliance, market analysis, competition analysis, manufacturing process improvement, technology, vertical integration, development-savvy

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 24 Oct 2017
Venture Round •••••• - 10 Aug 2015

Aavis Pharmaceuticals Alternatives & Competitors

Aavis Pharmaceuticals vs
TWi Pharmaceuticals, Inc.
TWi Pharmaceuticals, Inc. United States

Crafting specialized generic pharmaceuticals for the US market with advanced expertise in research,...

76 employees
Pharmaceutical
Compare Aavis Pharmaceuticals vs TWi Pharmaceuticals, Inc.
Aavis Pharmaceuticals vs
KLEVA Pharmaceuticals S.A.
KLEVA Pharmaceuticals S.A. Greece

Your Reliable Partner

129 employees
Health Care, Manufacturing
Compare Aavis Pharmaceuticals vs KLEVA Pharmaceuticals S.A.
Aavis Pharmaceuticals vs
Agno Pharma
Agno Pharma United States

Your Strategic & Reliable CDMO Since 2004

37 employees
Biotechnology, Health Care
Also compare with: Aavis Pharmaceuticals vs M.J. Biopharm Private Limited M.J. Biopharm Private Limited

FAQ About Aavis Pharmaceuticals

USFDA-approved manufacturer of specialty generic medications founded in 2015 and based in Hoschton, Georgia.
Aavis Pharmaceuticals was founded in 2015.
Aavis Pharmaceuticals is headquartered in United States.
Aavis Pharmaceuticals has approximately 50 employees.
Aavis Pharmaceuticals has completed 2 funding rounds, raising a total of $2.48M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Aavis Pharmaceuticals include TWi Pharmaceuticals, Inc., KLEVA Pharmaceuticals S.A., Agno Pharma, M.J. Biopharm Private Limited, InvaGen Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aavis Pharmaceuticals and TWi Pharmaceuticals, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Aavis Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy